Clinical Trial Update: Safety, Tolerability and PK 3-Period Crossover Study Comparing 2 Single Doses of ZTI-01 and Monurol® in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 crossover study in healthy subjects comparing two single doses of ZTI-01 and Monurol (fosfomycin tromethamine) to assess safety, tolerability, and pharm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pseudomonas Infection

Drugs mentioned

• Monurol (fosfomycin trometamol)
• ZTI-01

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Pseudomonas Infection | Phase 1 | Status: COMPLETED